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a b s t r a c t
This data article contains raw data and supplementary analyzed
data regarding to the article entitled “Effect of target temperature
management at 32–34 °C in cardiac arrest patients considering
assessment by regional cerebral oxygen saturation: A multicenter
retrospective cohort study”. We examined the effectiveness of
target temperature management (TTM) at 32–34 °C considering
degrees of patients’ cerebral injury and cerebral circulation
assessed by regional cerebral oxygen saturation (rSO2). The
research is a secondary analysis of prospectively collected registry,
in which comatose patients who were transferred to 15 hospitals
in Japan after out-of-hospital cardiac arrest (OHCA), and we
included 431 study patients. Propensity score analysis revealed
that TTM at 32–34 °C decreased all-cause mortality in patients
with rSO2 41–60%, and increased favorable neurological outcomes
in patients with rSO2 41–60% in the original research article. With
regard to the balance of covariates of propensity-score matching
(PSM) and inverse-probability weighting (IPW) analyses, some
covariates were not well balanced after the analyses between
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groups. The overlap plots indicate the overlap of densities of the
propensity scores are low in group rSO2 41–60% and group rSO2 Z
61%. When patients were limited to those who achieved return of
spontaneous circulation (ROSC) until/on hospitals arrival, TTM still
tended to decrease all-cause mortality and increase favorable
outcomes in group rSO2 41–60%.
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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The treatment, target temperature management (TTM) with 32–34 °C (12–




Data accessibility Data is available in this article
Related research
article
Effect of target temperature management at 32–34 °C in cardiac arrest
patients considering assessment by regional cerebral oxygen saturation: A
multicenter retrospective cohort study (in press)
Value of the data
 The data contain raw data and supplementary contents of our original paper, and these are
important information for interpretation the results of original research.
 TTM at 32–34 °C could be still effective when patients with rSO2 41–60% were limited to who
achieved ROSC until/on hospital arrival, excluding patients achieved ROSC after hospital arrival.
 The covariates of PSM and IPW analysis were not well balanced, and the overlap plots indicate the
overlap of densities of the propensity scores are low in group rSO2 41–60% and group rSO2 Z 61%.
 The use of TTM at 32–34 °C could be effective in patients with speciﬁc degrees of cerebral injury,
but the result should be interpreted carefully.
1. Data
We examined the effectiveness of TTM at 32–34 °C considering degrees of patients’ cerebral injury
and cerebral circulation assessed by regional cerebral oxygen saturation (rSO2). This is a secondary
analysis of prospectively collected registry [1,2], in which comatose patients who were transferred to
15 hospitals in Japan after out-of-hospital cardiac arrest (OHCA), and we included 431 study patients
(Table S1) [3]. In original research article, propensity score analysis revealed that TTM at 32–34 °C
decreased all-cause mortality in patients with rSO2 41–60% (average treatment effect on the treated
[ATT] by propensity score matching [PSM] −0.51, 95%CI −0.70 to −0.33; ATT by inverse probability of
treatment weighting [IPW] −0.52, 95%CI −0.71 to −0.34), and increased favorable neurological
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outcomes in patients with rSO2 41–60% (ATT by PSM 0.50, 95%CI 0.32–0.68; ATT by IPW 0.52, 95%CI
0.35–0.69). TTM at 32–34 °C could be effective to decrease all-cause mortality in comatose OHCA
patients with rSO2 41–60% on hospital arrival. Tables 1–4 show that the covariates of PSM and IPW
analysis were not well balanced. The overlap plots (Figs. 1 and 2) show the overlap of densities of the
propensity scores are low in group rSO2 41–60% and group rSO2 Z 61%, this indicates the overlap
assumption on the treatment effect on the potential-outcome models may be violated. Table 5 shows
that TTM could be still effective when patients with rSO2 41–60% were limited to who achieved ROSC
until/on hospital arrival, excluding patients achieved ROSC after hospital arrival.
2. Experimental design, materials, and methods
2.1. Study design and data source
The original research article is a secondary analysis of prospectively collected registry, the Japan-
Prediction of Neurological Outcomes in Patients Post-cardiac Arrest Registry [UMIN trial ID
000005065] [2,3], in which OHCA patients transported to 15 tertiary emergency hospitals in Japan
from May 2011 to August 2013 were consecutively registered. The database consists of pre-hospital
and in-hospital data collected from the Japanese emergency medical service (EMS) system and
medical charts of each hospital by using the Utstein style [4].
2.2. Study population
Comatose patients after OHCA were included in this study if they achieved ROSC. Exclusion criteria
were trauma, accidental hypothermia, age o18 years, completion of “Do Not Resuscitate [5]” orders,
and a Glasgow coma scale (GCS) score of 48 on arrival at the hospital.
After arriving at hospital, two disposable probes of NIRS (INVOS TM 5100C, Covidien, Boulder, CO,
USA) were attached to the patient's forehead. rSO2 was monitored at least for 1 minute with the
probes after several seconds of stable monitoring, and the lowest rSO2 value was used.
Patients were stratiﬁed into three groups according to the recorded rSO2: group rSO2 Z61% (G1),
group rSO2 41–60% (G2), and group rSO2 r40% (G3), by referring to previous studies which suggest
that values less than 35–40% or an absolute decrease of 20% from baseline should alert clinicians to
perform appropriate interventions to reverse potential cerebral hypoxemia [6–10], and reported that
rSO2 values are 60% or higher in most stable patients [7,9,11].
2.3. Variables
2.3.1. Treatment and outcome measurement
The treatment, TTM with 32 to 34°C (12–24 h) was conducted by the discretion of the attending
physician.
We deﬁned the primary outcome as all-cause mortality at 90 days after cardiac arrest, and the
secondary outcome as favorable neurological outcome evaluated according to the Cerebral Perfor-
mance Category (CPC) [12]. The CPC is a 5-point scale ranging from 1 (good cerebral performance) to
5 (dead). We deﬁned favorable neurological outcome as a CPC 1 or 2 by reference to the international
guidelines [13,14]. Both all-cause mortality and neurological outcome are core elements in the
guidelines. In principle, CPC in individual patients were determined by the physician-in-charge, but in
cases of missing data, the main researcher who developed the database determined CPC by contacting
patients or family members; both were blinded to rSO2 readings.
2.3.2. Covariates
We used patient characteristics as covariates, including demographic characteristics (sex, age),
pre-hospital status (location of arrest, witnessed arrest, bystander CPR, ﬁrst monitored rhythm), pre-
hospital resuscitation attempts by EMS (airway management by intubation or laryngeal mask airway
device, intravenous injection of adrenaline, usage of Automated External Deﬁbrillator [AED]), patient
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Table 1
Balance of covariates of propensity score matching analysis for all-cause mortalitya.
Covariates rSO2 Z 61%, G1 (N ¼ 68, 34 pairs) rSO2 41–60%, G2 (N ¼ 67, 31 pairs) rSO2 15–40%, G3 (N¼296, 54 pairs)

























Sex 0.36 −0.37 0.65 2.63 0.25 1.09 0.82 1.0 0.28 0.040 0.86 0.97
Age 0.38 −0.14 0.83 2.25 −1.52 0.11 2.47 0.99 −0.18 −0.22 0.69 0.77
Location of cardiac arrest 0.37 −0.16 1.04 1.66 0.71 −0.40 1.59 0.78 0.41 −0.074 1.23 0.97
Witness 0.092 −0.58 0.84 – 0.13 −0.35 0.87 2.00 0.44 −0.14 0.68 1.29
Type of bystander-witness status 0.14 −0.37 1.09 3.25 0.25 0.46 1.13 2.97 0.37 −0.17 0.95 0.97
Bystander-initiated CPR 0.15 −0.63 1.004 1.38 0.22 −0.47 1.04 1.30 0.27 −0.11 1.14 0.996
Initially documented rhythms on
the scene of cardiac arrest
−0.40 0.024 1.73 1.10 0.32 0.073 4.76 24.31 −0.72 −0.36 1.27 0.83
Pre-hospital procedures
Advanced airway device 0.15 0.70 1.004 1.52 -0.77 0.066 1.27 1.04 -0.17 -0.11 1.09 1.04
Intravenous epinephrine
administration
0.21 0.47 0.84 2.42 -0.95 -0.21 0.78 0.80 -0.33 -0.34 0.70 0.68
Deﬁbrillation 1.65 0.0 0.98 1.0 1.27 1.27 8.26 8.00 0.52 0.26 2.47 1.38
ROSC until/on hospital arrival 0.46 -0.51 0.49 – 0.52 1.09 0.70 0.85 0.36 0.17 3.12 1.50
Emergency call to hospital arrival -0.56 -0.36 0.12 0.097 -0.059 0.29 3.75 9.44 -0.45 -0.57 0.38 0.39
rSO2 at hospital arrival -0.51 -0.051 0.52 1.72 0.21 0.071 0.70 1.37 0.39 0.28 1.43 1.26
Rhythms at rSO2 measurement 0.50 -0.45 0.39 – 0.34 1.03 1.02 0.93 -0.32 -0.20 2.16 1.50
Procedures after hospital arrival
Coronary angiography 1.14 -0.19 1.47 1.22 0.98 1.10 4.23 7.93 0.94 0.99 5.45 6.77
Primary percutaneous coronary
intervention
-0.098 -1.69 0.81 0.58 0.60 0.75 5.78 – 0.49 0.39 7.59 3.54
SD¼standard deviation, CPR¼cardiopulmonary resuscitation, ROSC¼return of spontaneous circulation.















Balance of covariates of propensity score matching analysis for favorable neurological outcomesa.
Covariates rSO2 Z61%, G1 (N ¼ 68, 34 pairs) rSO2 41–60%, G2 (N ¼ 67, 31 pairs) rSO2 15–40%, G3 (N¼296, 54 pairs)

























Sex 0.36 −0.37 0.65 2.63 0.25 1.09 0.82 1.00 0.28 0.040 0.86 0.97
Age −0.38 −0.14 0.83 2.25 1.52 0.11 2.47 0.99 −0.18 −0.22 0.69 0.77
Location of cardiac arrest 0.37 −0.16 1.04 1.66 0.71 −0.40 1.59 0.78 0.041 −0.074 1.23 0.97
Witness 0.092 −0.58 0.84 – 0.13 −0.35 0.87 2.00 0.44 −0.14 0.68 1.29
Type of bystander-witness status 0.14 −0.37 1.09 3.25 0.25 0.46 1.13 2.97 0.37 −0.17 0.95 0.97
Bystander-initiated CPR −0.15 −0.63 1.004 1.38 0.22 -0.47 1.04 1.30 0.27 −0.11 1.14 0.996
Initially documented rhythms on
the scene of cardiac arrest
−0.40 0.024 1.73 1.10 0.32 0.073 4.76 24.31 −0.72 −0.36 1.27 0.83
Pre-hospital procedures
Advanced airway devices 0.15 0.70 1.004 1.52 −0.77 0.066 1.27 1.04 −0.17 −0.11 1.09 1.04
Intravenous epinephrine
administration
−0.21 0.47 0.84 2.42 −0.95 −0.21 0.78 0.80 −0.33 −0.34 0.70 0.68
Deﬁbrillation 1.65 0.0 0.98 1.00 1.27 1.27 8.26 8.00 0.52 0.26 2.47 1.38
ROSC until/on hospital arrival 0.46 −0.51 0.49 – 0.52 1.09 0.70 0.85 0.36 0.17 3.11 1.50
Emergency call to hospital arrival −0.56 −0.36 0.12 0.097 −0.059 0.29 3.75 9.44 −0.45 −0.57 0.38 0.39
rSO2 at hospital arrival 0.51 −0.051 0.52 1.72 0.21 0.071 0.70 1.37 0.39 0.28 1.43 1.26
Rhythms at rSO2 measurement 0.50 −0.45 0.39 – 0.34 1.03 1.02 0.93 −0.32 −0.20 2.16 1.50
Procedures after hospital arrival
Coronary angiography 1.14 −0.19 1.47 1.22 0.98 1.10 4.23 7.93 0.94 0.99 5.45 6.77
Primary percutaneous coronary
intervention
−0.098 −1.69 0.81 0.58 0.60 0.75 5.78 – 0.49 0.39 7.59 3.54
SD¼standard deviation, CPR¼cardiopulmonary resuscitation, ROSC¼return of spontaneous circulation.















Balance of covariates of inverse probability of treatment weighting for all-cause mortalitya.
Covariates rSO2 Z 61%, G1 (N ¼ 45) rSO2 41–60%, G2 (N ¼ 42) rSO2 15–40%, G3 (N ¼ 228)

























Sex 0.36 0.062 0.65 0.90 0.25 0.075 0.82 1.001 0.28 −0.061 0.86 1.02
Age −0.38 0.069 0.83 1.06 −1.52 0.17 2.47 0.86 −0.18 −0.14 0.69 0.86
Location of cardiac arrest 0.37 −0.045 1.04 1.48 0.71 −0.29 1.59 0.75 0.41 0.21 1.23 1.14
Witness 0.092 −0.10 0.84 1.27 0.13 −0.54 0.87 1.50 0.44 0.13 0.68 0.92
Type of bystander-witness status 0.14 −0.17 1.09 1.43 0.25 −0.049 1.13 1.70 0.37 0.076 0.95 0.89
Bystander-initiated CPR −0.15 −0.54 1.004 1.16 0.22 −0.47 1.04 0.94 0.27 0.080 1.14 1.04
Initially documented rhythms on the
scene of cardiac arrest
−0.40 0.24 1.73 1.14 −0.32 0.17 4.76 4.43 −0.72 −0.44 1.27 0.79
Pre-hospital procedures
Advanced airway devices 0.15 0.77 1.004 1.24 −0.77 −0.45 1.27 0.81 0.17 −0.060 1.09 1.03
Intravenous epinephrine
administration
−0.21 0.21 0.84 1.31 −0.95 −0.59 0.78 0.58 0.33 −0.33 0.70 0.68
Deﬁbrillation 1.65 0.44 0.98 0.82 1.27 0.76 8.26 6.93 0.52 0.26 2.47 1.62
ROSC at hospital arrival 0.46 0.093 0.49 0.85 0.52 0.35 0.70 1.09 0.36 0.00084 3.12 1.003
Emergency call to hospital arrival 0.56 −0.37 0.12 0.059 −0.059 0.00062 3.75 2.33 0.45 −0.43 0.38 0.36
rSO2 at hospital arrival 0.51 −0.38 0.52 0.69 0.21 −0.082 0.70 0.66 0.39 0.34 1.43 1.22
Rhythms at rSO2 measurement 0.50 0.20 0.39 0.54 0.34 0.61 1.02 0.70 −0.32 −0.39 2.16 1.21
Procedures after hospital arrival
Coronary angiography 1.14 0.11 1.47 0.99 0.98 0.64 4.23 4.92 0.94 0.78 5.45 4.13
Primary percutaneous coronary
intervention
−0.098 −1.02 0.81 0.27 0.60 0.42 5.78 6.73 0.49 0.44 7.59 5.01
SD ¼ standard deviation, CPR ¼ cardiopulmonary resuscitation, ROSC ¼ return of spontaneous circulation.















Balance of covariates of inverse probability of treatment weighting for favorable neurological outcomesa.
Covariates rSO2 Z61%, G1 (N ¼ 68) rSO2 41–60%, G2 (N ¼ 67) rSO2 15–40%, G3 (N ¼ 296)

























Sex 0.36 0.062 0.65 0.90 0.25 0.32 0.82 0.97 0.28 0.036 0.86 0.99
Age −0.38 0.069 0.83 1.06 1.52 −0.0051 2.47 0.77 −0.18 −0.28 0.69 0.63
Location of cardiac arrest 0.37 −0.045 1.04 1.48 0.71 0.092 1.59 0.76 0.41 0.11 1.23 1.21
Witness 0.092 −0.10 0.84 1.27 0.13 −0.22 0.87 1.32 0.44 0.022 0.68 0.99
Type of bystander-witness status 0.14 −0.17 1.09 1.43 0.25 0.17 1.13 1.49 0.37 -0.074 0.95 0.77
Bystander-initiated CPR −0.15 −0.54 1.004 1.16 0.22 −0.32 1.04 0.99 0.27 0.0072 1.14 1.004
Initially documented rhythms on the
scene of cardiac arrest
0.40 0.24 1.73 1.14 −0.32 0.25 4.76 4.85 −0.72 −0.75 1.27 0.59
Pre-hospital procedures
Advanced airway devices 0.15 0.77 1.004 1.24 −0.77 −0.35 1.27 0.96 −0.17 −0.43 1.09 1.05
Intravenous epinephrine
administration
−0.21 0.21 0.84 1.31 −0.95 −0.76 0.78 0.53 −0.33 −0.37 0.70 0.64
Deﬁbrillation 1.65 0.44 0.98 0.82 1.27 0.77 8.26 6.85 0.52 0.064 2.47 1.16
ROSC at hospital arrival 0.46 0.093 0.49 0.85 0.52 0.16 0.70 1.03 0.36 0.059 3.12 1.25
Emergency call to hospital arrival 0.56 −0.37 0.12 0.059 0.059 −0.082 3.73 2.67 0.45 −0.28 0.38 0.44
rSO2 at hospital arrival −0.51 −0.38 0.52 0.69 0.21 0.00 0.70 0.81 0.39 0.086 1.43 1.10
Rhythms at rSO2 measurement 0.50 0.20 0.39 0.54 0.34 0.18 1.02 1.04 0.32 −0.26 2.16 1.23
Procedures after hospital arrival
Coronary angiography 1.14 0.11 1.47 0.99 0.98 0.56 4.23 4.00 0.94 0.51 5.45 3.87
Primary percutaneous coronary
intervention
−0.098 −1.02 0.81 0.27 0.60 0.40 5.78 6.32 0.49 0.21 7.59 2.87
SD¼standard deviation, CPR¼cardiopulmonary resuscitation, ROSC¼return of spontaneous circulation.














status at emergency unit (time from emergency call to hospital arrival, rhythm of electrocardiogram
on rSO2 measurement), cardiac origin or not (presumed by attending physician retrospectively), and
procedures after hospitalization (ECPR, coronary angiography, primary percutaneous coronary
intervention).
2.4. Statistical analyses
In original research article, effectiveness of TTM was evaluated by group according to rSO2. Risk
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Fig. 1. Overlap plots of propensity score matching analysis and inverse probability of treatment weighting for all-cause
mortality.
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Table 5
Analysis results on the effectiveness of target temperature management (32–34 °C) for all-cause mortality or favorable neurological outcomes of patients those who achieved return of
spontaneous circulation until/on hospital arrival (n ¼ 117).














Risk ratio 0.29 0.36 0.70 1.87 11.52 1.22
[95%CI] [0.11 to 0.80] [0.20 to 0.65] [0.30 to 1.64] [1.06 to 3.29] [1.68 to 79.15] [0.32 to 4.65]
Risk difference 0.33 -0.57 -0.19 0.33 0.58 0.061
[95%CI] [-0.56 to -0.091] [-0.80 to -0.34] [-0.62 to 0.24] [0.071 to 0.58] [0.37 to 0.80] [-0.34 to 0.47]
Multivariate logistic
regressiona
Odds ratio 0.36 0.16 4.65e-06 1.33 22.63 1.25
[95%CI] [0.040 to 3.25] [0.0061 to 4.33] [5.11e-14 to 423.43] [0.25 to 7.11] [0.50 to 1016.29] [0.13 to 12.47]
Propensity-score matchingb
ATE -0.074 -0.63 -0.15 0.074 0.63 0.050
[95%CI] [-0.42 to 0.27] [-0.86 to -0.40] [-0.66 to 0.36] [-0.012 to 0.16] [0.40 to 0.86] [-0.22 to 0.32]
ATT 0.033 -0.68 -0.44 -0.067 0.64 0.22
[95%CI] [-0.17 to 0.24] [-0.86 to -0.50] [-0.74 to -0.14] [-0.33 to 0.20] [0.46 to 0.82] [-0.19 to 0.64]
IPWb
ATE -0.051 -0.52 -0.29 0.061 0.53 0.045
[95%CI] [-0.30 to 0.19] [-0.78 to -0.26] [-0.55 to -0.038] [-0.19 to 0.31] [0.28 to 0.78] [-0.29 to 0.38]
ATT 0.034 -0.64 -0.42 -0.098 0.61 0.22
[95%CI] [-0.18 to 0.25] [-0.84 to -0.44] [-0.72 to -0.12] [-0.37 to 0.18] [0.40 to 0.81] [-0.18 to 0.62]
TTM¼target temperature management, CPC¼cerebral performance category, ATE¼average treatment effect, ATT¼average treatment effect on the treated, IPW¼ inverse probability of
treatment weighting.
a In multivariate logistic analysis, explanatory variables including sex, age, witnessed arrest, PaO2, PaCO2, ﬁrst monitored rhythm (shockable [VF/pulseless VT]/non-shockable [PEA,
asystole, unknown]) were used for statistical adjustment.
b We used age, sex, witnessed arrest, PaO2, PaCO2, ﬁrst monitored rhythm (shockable [VF/pulseless VT] / non-shockable [PEA, asystole, unknown]) as covariates for estimating the PS,














explanatory variables including sex, age, witnessed arrest, PaO2, PaCO2, ﬁrst monitored rhythm
(shockable [VF/pulseless VT] / non-shockable [PEA, asystole, unknown]) were used for statistical
adjustment. Treatment effect estimation was also performed by propensity-score matching (PSM) and
inverse-probability weighting (IPW), in order to adjust for differences in baseline characteristics [15–
18]. All analyses were performed with Stata SE, version 14.0 (Stata Corp., College Station, TX, USA).
Tests of statistical signiﬁcance were two-tailed with an alpha of 0.05.
Potential-outcome models, also known as Rubin causal models, were used to estimate the dis-
tribution of individual-level treatment effects, i.e., changes in outcome caused by receiving one
treatment over another [17,18]. We used the average treatment effect (ATE: average effect of the
treatment in the population) and average treatment effect on the treated (ATT: average treatment
effect among those who received the treatment).
In PSM analysis, we performed nearest neighbor matching within caliper [16]. We basically used
age, sex, witnessed arrest, PaO2, PaCO2 and ﬁrst monitored rhythm (shockable / non-shockable) as
covariates for estimating the propensity score (PS), and if possible, more variables relating to patient
characteristics observed before TTM were also used to increase the accuracy of the PS model. We used
calipers of width 0.2*(SD of log PS) for matching and also included interaction and higher order terms.
In IPW analysis, we basically used same covariates as PSM, and if possible, more variables observed
before TTM were used, including interaction and higher order terms. We showed balances of cov-
ariates (Tables 1–4) and overlap plots (Figs. 1 and 2) of PSM and IPW analysis. Sensitivity analyses
were performed by limiting patients to those who achieved ROSC upon hospitals arrival (excluding
patients with ROSC after arrival) (Table 5).
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